Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hesham S Al-Sallami

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
British Journal of Clinical Pharmacology|January 16, 2025
Spotlight commentary: Changes in pharmacokinetics following significant weight lossAndrej Belančić, Hesham S Al-Sallami
The Journal of Pharmacy and Pharmacology|January 6, 2015
Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasmaHesham S Al-Sallami, Natalie J Medlicott
Clinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Clinical Pharmacokinetics|May 24, 2020
Authors' Reply to Friesen: "An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities"Jaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Journal of Pharmacokinetics and Pharmacodynamics|March 2, 2021
Reduction of quantitative systems pharmacology models using artificial neural networksAbdallah Derbalah, Hesham S Al-Sallami, Stephen B Duffull
Clinical Pharmacokinetics|January 14, 2018
A Review of the Methods and Associated Mathematical Models Used in the Measurement of Fat-Free MassJaydeep Sinha, Stephen B Duffull, Hesham S Al-Sallami
Clinical Pharmacokinetics|April 29, 2018
Choosing the Allometric Exponent in Covariate Model BuildingJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
British Journal of Clinical Pharmacology|February 24, 2026
Lean body weight should guide enoxaparin dosing in obesity: A response to Roberts et alHesham S Al-Sallami, Michael Barras, Daniel F Wright
Clinical Pharmacokinetics|October 5, 2019
Evaluating the Relationship Between Lean Liver Volume and Fat-Free MassJaydeep Sinha, Stephen B Duffull, Bruce Green, et al.
British Journal of Clinical Pharmacology|April 27, 2013
Is the dose of dabigatran really more predictable than warfarin?Daniel F B Wright, Hesham S Al-Sallami, Stephen B Duffull
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
British Journal of Clinical Pharmacology|January 16, 2025
Spotlight commentary: Changes in pharmacokinetics following significant weight lossAndrej Belančić, Hesham S Al-Sallami
The Journal of Pharmacy and Pharmacology|January 6, 2015
Investigation of an anti-activated factor X (anti-Xa) assay for the quantification of enoxaparin in human plasmaHesham S Al-Sallami, Natalie J Medlicott
Clinical Pharmacokinetics|March 24, 2020
An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different EthnicitiesJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Clinical Pharmacokinetics|May 24, 2020
Authors' Reply to Friesen: "An Extension of Janmahasatian's Fat-Free Mass Model for Universal Application Across Populations of Different Ethnicities"Jaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
Journal of Pharmacokinetics and Pharmacodynamics|March 2, 2021
Reduction of quantitative systems pharmacology models using artificial neural networksAbdallah Derbalah, Hesham S Al-Sallami, Stephen B Duffull
Clinical Pharmacokinetics|January 14, 2018
A Review of the Methods and Associated Mathematical Models Used in the Measurement of Fat-Free MassJaydeep Sinha, Stephen B Duffull, Hesham S Al-Sallami
Clinical Pharmacokinetics|April 29, 2018
Choosing the Allometric Exponent in Covariate Model BuildingJaydeep Sinha, Hesham S Al-Sallami, Stephen B Duffull
British Journal of Clinical Pharmacology|February 24, 2026
Lean body weight should guide enoxaparin dosing in obesity: A response to Roberts et alHesham S Al-Sallami, Michael Barras, Daniel F Wright
Clinical Pharmacokinetics|October 5, 2019
Evaluating the Relationship Between Lean Liver Volume and Fat-Free MassJaydeep Sinha, Stephen B Duffull, Bruce Green, et al.
British Journal of Clinical Pharmacology|April 27, 2013
Is the dose of dabigatran really more predictable than warfarin?Daniel F B Wright, Hesham S Al-Sallami, Stephen B Duffull
Pageof 4